CIRSE 2011: Indications for TACE, including diffuse lesions, are expanding rapidly

Decrease font size Reset font size Increase font size

Published 16 September 2011 | Article by Excerpta Medica

CIRSE 2011: Indications for TACE, including diffuse lesions, are expanding rapidly

In this 4-minute video interview conducted at the 2011 meeting of CIRSE, Dr Hicham Kobeiter, Professor of Medicine, Henri Mondor University Hospital, Paris XII University, Creteil, France, reports that transcatheter arterial chemoembolization (TACE) is being employed in an increasingly broad range of applications. He credits better imaging that has improved the targeting of TACE.

To read the full article, please register for GetInsideHealth below.

Register for GetInsideHealth

GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.

Please fill in the form below to register.

Already Registered?

Please login using
form at top of page

Fields with an asterisk (*) are mandatory

About you

Title

First Name *

Last Name *

Login information

Email Address *

Password (minimum 7 characters) *

Repeat Password *

Tick the box if you want to receive the GetInsideHealth newsletter and other email updates

To personalise your experience, please specify which specialty areas you are interested in

Cardiology

OBGYN

Oncology

Radiology

Health & Well-Being

If you’re interested in receiving occasional e-mail updates from our sponsor, please click here to allow us to share your e-mail address and basic contact information. Your data will not be used by any third party, and you can unsubscribe at any time.